Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biochemical Journal

• Publication date

  2015-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BJ20150650PMID 26431849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progress and problems with the use of suicide genes for targeted cancer therapy.

  2016cited by this paper
• In vivo imaging and detection of nitroreductase in zebrafish by a new near-infrared fluorescence off-on probe.

  2015cited by this paper
• Differential fates of biomolecules delivered to target cells via extracellular vesicles

  2015cited by this paper
• A rapid response "Turn-On" fluorescent probe for nitroreductase detection and its application in hypoxic tumor cell imaging.

  2015cited by this paper
• Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma

  2015cited by this paper
• Effects of metronidazole on proopiomelanocortin a gene expression in zebrafish.

  2015cited by this paper
• Ruthenium-caged antisense morpholinos for regulating gene expression in zebrafish embryos

  2015cited by this paper
• The potential of clostridial spores as therapeutic delivery vehicles in tumour therapy.

  2015cited by this paper
• Real time detection of live microbes using a highly sensitive bioluminescent nitroreductase probe.

  2015cited by this paper
• A gain-of-function positive-selection expression plasmid that enables high-efficiency cloning

  2015cited by this paper
• A "Caged" Luciferin for Imaging Cell-Cell Contacts.

  2015cited by this paper
• Gefitinib and erlotinib in metastatic non-small cell lung cancer: a meta-analysis of toxicity and efficacy of randomized clinical trials.

  2015cited by this paper
• Development of a Bioluminescent Nitroreductase Probe for Preclinical Imaging

  2015cited by this paper
• SOS, the formidable strategy of bacteria against aggressions.

  2014cited by this paper
• Understanding the Broad Substrate Repertoire of Nitroreductase Based on Its Kinetic Mechanism*

  2014cited by this paper
• Noninvasive Theranostic Imaging of HSV1-sr39TK-NTR/GCV-CB1954 Dual-Prodrug Therapy in Metastatic Lung Lesions of MDA-MB-231 Triple Negative Breast Cancer in Mice

  2014cited by this paper
• Toward a high-throughput screening platform for directed evolution of enzymes that activate genotoxic prodrugs.

  2014cited by this paper
• Nitroreductase-Activatable Morpholino Oligonucleotides for in Vivo Gene Silencing

  2014cited by this paper
• Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer.

  2014cited by this paper
• Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo

  2014cited by this paper
• A cresyl violet-based fluorescent off-on probe for the detection and imaging of hypoxia and nitroreductase in living organisms.

  2014cited by this paper
• Pseudomonas aeruginosa MdaB and WrbA are water-soluble two-electron quinone oxidoreductases with the potential to defend against oxidative stress

  2014cited by this paper
• Enhanced Cell-Specific Ablation in Zebrafish Using a Triple Mutant of Escherichia Coli Nitroreductase

  2014cited by this paper
• Directed Evolution Library Creation

  2014cited by this paper
• Nitroreductase detection and hypoxic tumor cell imaging by a designed sensitive and selective fluorescent probe, 7-[(5-nitrofuran-2-yl)methoxy]-3H-phenoxazin-3-one.

  2013cited by this paper
• Pseudomonas aeruginosa NfsB and nitro-CBI-DEI – a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy

  2013cited by this paper
• Creation and screening of a multi-family bacterial oxidoreductase library to discover novel nitroreductases that efficiently activate the bioreductive prodrugs CB1954 and PR-104A.

  2013cited by this paper
• Bacterial-directed enzyme prodrug therapy.

  2013cited by this paper
• A highly sensitive long-wavelength fluorescence probe for nitroreductase and hypoxia: selective detection and quantification.

  2013cited by this paper
• Morpholino-mediated knockdown of ERα, ERβa, and ERβb mRNAs in zebrafish (Danio rerio) embryos reveals differential regulation of estrogen-inducible genes.

  2013cited by this paper
• Nitroreductase, a near-infrared reporter platform for in vivo time-domain optical imaging of metastatic cancer.

  2013cited by this paper
• The nitroreductase system of inducible targeted ablation facilitates cell-specific regenerative studies in zebrafish.

  2013cited by this paper
• Role of Autofluorescence in Flow Cytometric Analysis of Escherichia coli Treated with Bactericidal Antibiotics

  2013cited by this paper
• Escherichia coli NemA Is an Efficient Chromate Reductase That Can Be Biologically Immobilized to Provide a Cell Free System for Remediation of Hexavalent Chromium

  2013cited by this paper
• The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy

  2013cited by this paper
• Noninvasive Molecular Imaging Using Reporter Genes

  2013cited by this paper
• Cancer drug resistance: an evolving paradigm

  2013cited by this paper
• Ganciclovir

  2012cited by this paper
• Structure of RdxA – an oxygen‐insensitive nitroreductase essential for metronidazole activation in Helicobacter pylori

  2012cited by this paper
• Characterisation of enzyme prodrug gene therapy combinations in coated spheroids and vascular networks in vitro

  2012cited by this paper
• Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients

  2012cited by this paper
• Circumventing cancer drug resistance in the era of personalized medicine.

  2012cited by this paper
• Theranostic Potential of Oncolytic Vaccinia Virus

  2012cited by this paper
• An unusually cold active nitroreductase for prodrug activations.

  2012cited by this paper
• High Resolution In Vivo Bioluminescent Imaging for the Study of Bacterial Tumour Targeting

  2012cited by this paper
• Targeted mutagenesis of the Vibrio fischeri flavin reductase FRase I to improve activation of the anticancer prodrug CB1954.

  2012cited by this paper
• Manipulation of gene expression in zebrafish using caged circular morpholino oligomers

  2012cited by this paper
• Suicide gene therapy in cancer: where do we stand now?

  2012cited by this paper
• Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs.

  2011cited by this paper
• Advances in imaging gene-directed enzyme prodrug therapy.

  2011cited by this paper
• Colloidal gold modified with a genetically engineered nitroreductase: toward a novel enzyme delivery system for cancer prodrug therapy.

  2011cited by this paper
• A new prodrug-derived ratiometric fluorescent probe for hypoxia: high selectivity of nitroreductase and imaging in tumor cell.

  2011cited by this paper
• A combined pharmacokinetic model for the hypoxia-targeted prodrug PR-104A in humans, dogs, rats and mice predicts species differences in clearance and toxicity

  2011cited by this paper
• A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients

  2011cited by this paper
• Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial).

  2011cited by this paper
• Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302

  2011cited by this paper
• NEAR-INFRARED DYES: Probe Development and Applications in Optical Molecular Imaging.

  2011cited by this paper
• Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice

  2011cited by this paper
• Selective treatment of hypoxic tumor cells in vivo: phosphate pre-prodrugs of nitro analogues of the duocarmycins.

  2011cited by this paper
• Use of a direct, positive selection strategy to generate improved prodrug-activating enzymes for cancer gene therapy

  2011cited by this paper
• Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

  2011cited by this paper
• Noninvasive optical imaging of nitroreductase gene-directed enzyme prodrug therapy system in living animals

  2011cited by this paper
• Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• uvrB gene deletion enhances SOS chromotest sensitivity for nitroreductases that preferentially generate the 4-hydroxylamine metabolite of the anti-cancer prodrug CB1954.

  2010cited by this paper
• Testing double mutants of the enzyme nitroreductase for enhanced cell sensitisation to prodrugs: effects of combining beneficial single mutations.

  2010cited by this paper
• Engineering the perfect (bacterial) cancer therapy

  2010cited by this paper
• Escherichia coli ferredoxin-NADP+ reductase and oxygen-insensitive nitroreductase are capable of functioning as ferric reductase and of driving the Fenton reaction

  2010cited by this paper
• The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3.

  2010cited by this paper
• The adenovirus-mediated linamarase/linamarin suicide system: a potential strategy for the treatment of hepatocellular carcinoma.

  2010cited by this paper
• Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors

  2010cited by this paper
• A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors

  2010cited by this paper
• NADH oxidase activity of Bacillus subtilis nitroreductase NfrA1: Insight into its biological role

  2010cited by this paper
• Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954.

  2010cited by this paper
• Nitroaromatic Compounds, from Synthesis to Biodegradation

  2010cited by this paper
• Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy

  2010cited by this paper
• Steady-state and stopped-flow kinetic studies of three Escherichia coli NfsB mutants with enhanced activity for the prodrug CB1954.

  2009cited by this paper
• Roles of DNA repair and reductase activity in the cytotoxicity of the hypoxia-activated dinitrobenzamide mustard PR-104A

  2009cited by this paper
• Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N3 DNA minor groove alkylators

  2009cited by this paper
• Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with glioma

  2009cited by this paper
• Directed enzyme evolution: climbing fitness peaks one amino acid at a time.

  2009cited by this paper
• CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy

  2009cited by this paper
• The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis.

  2009cited by this paper
• Exploring protein fitness landscapes by directed evolution

  2009cited by this paper
• Nitroreductase from Bacillus licheniformis: a stable enzyme for prodrug activation.

  2009cited by this paper
• E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954

  2009cited by this paper
• Bystander or No Bystander for Gene Directed Enzyme Prodrug Therapy

  2009cited by this paper
• A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1984.

  2009cited by this paper
• DNA cross-links in human tumor cells exposed to the prodrug PR-104A: relationships to hypoxia, bioreductive metabolism, and cytotoxicity.

  2009cited by this paper
• Antitumor activity of a selectively replication competent herpes simplex virus (HSV) with enzyme prodrug therapy.

  2009cited by this paper
• Antivector and tumor immune responses following adenovirus-directed enzyme prodrug therapy for the treatment of prostate cancer.

  2009cited by this paper
• Methods to monitor gene therapy with molecular imaging.

  2009cited by this paper
• A Primer for Morpholino Use in Zebrafish

  2009cited by this paper
• Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori

  2009cited by this paper
• A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].

  2009cited by this paper
• Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

  2008cited by this paper
• NAD+/NADH and NADP+/NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences

  2008cited by this paper
• 18F-EF5: A New PET Tracer for Imaging Hypoxia in Head and Neck Cancer

  2008cited by this paper
• A history of cancer chemotherapy.

  2008cited by this paper
• Metabolic activation of the antitumor drug 5-(Aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by NO synthases.

  2008cited by this paper

• A review on simultaneous use of microbes and biochar for removal of toxic heavy metals: Recent updates and future outlooks

  2025cites this paper
• Novel TdsD nitroreductase: characterization of kinetics and substrate specificity

  2025influential citation
• Targeting nitroreductases for selective drug activation: therapeutic perspectives in neglected diseases and tuberculosis.

  2025cites this paper
• Dual-Lock System for High Sensitivity and Selectivity in Redox Enzyme Activation and Imaging.

  2025cites this paper
• Deciphering spread of quinolone resistance in mariculture ponds: Cross-species and cross-environment transmission of resistome.

  2025cites this paper
• Reactions of Plasmodium falciparum Type II NADH: Ubiquinone Oxidoreductase with Nonphysiological Quinoidal and Nitroaromatic Oxidants

  2025cites this paper
• Design, synthesis and in vitro evaluation of non-steroidal anti-inflammatory prodrugs for osteoarthritis.

  2025cites this paper
• Extracellular respiration is a latent energy metabolism in Escherichia coli.

  2025cites this paper
• 1H Parashift Probes for Ratiometric Detection of Nitroreductase.

  2025cites this paper
• A nanoengineered tandem nitroreductase: designing a robust prodrug-activating nanoreactor

  2024cites this paper
• Phenoxy-1,2-dioxetane-based activatable chemiluminescent probes: tuning of photophysical properties for tracing enzymatic activities in living cells.

  2024cites this paper
• Prodrug activation by 4,4’-bipyridine-mediated aromatic nitro reduction

  2024cites this paper
• Characterization and Molecular Insights of a Chromium-Reducing Bacterium Bacillus tropicus

  2024cites this paper
• Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities

  2024cites this paper
• Smart nanocarriers for enzyme-activated prodrug therapy

  2024cites this paper
• Recent advances and applications of nitroreductase activable agents for tumor theranostic

  2024cites this paper
• Biochemical, kinetic, and structural characterization of a Bacillus tequilensis nitroreductase

  2024cites this paper
• Structural Evaluation of a Nitroreductase Engineered for Improved Activation of the 5-Nitroimidazole PET Probe SN33623

  2024cites this paper
• Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug.

  2024cites this paper
• The Catalysis Mechanism of E. coli Nitroreductase A, a Candidate for Gene-Directed Prodrug Therapy: Potentiometric and Substrate Specificity Studies

  2024influential citation
• Reporter cell lines to screen for inhibitors or regulators of the KRAS-RAF-MEK1/2-ERK1/2 pathway

  2024cites this paper
• Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery

  2024cites this paper
• A mitochondrial targeted fluorescent probe for imaging nitroreductase activity and photodynamic therapy in tumor cells.

  2024cites this paper
• Engineering an asymmetric rhodamine dye suitable for developing ratiometric fluorescent probe

  2023cites this paper
• Bacterial amidohydrolases and modified 5-fluorocytidine compounds: Novel enzyme-prodrug pairs

  2023cites this paper
• Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells

  2023cites this paper
• Stimuli-responsive Compounds as Emerging Anticancer and Cell Imaging Agents

  2023cites this paper
• A metagenomic library cloning strategy that promotes high-level expression of captured genes to enable efficient functional screening

  2023cites this paper
• A novel nitroreductase-responsive turn-off fluorescent probe based on AIEgen and its bioimaging application

  2023cites this paper
• Rational design of a ratiometric fluorescent probe for imaging lysosomal nitroreductase activity.

  2023cites this paper
• The dinitrobenzamide mustard prodrugs, PR-104A and SN27686, for use in a novel MNDEPT cancer prodrug therapy approach

  2023cites this paper
• The Crystal Structure of Engineered Nitroreductase NTR 2.0 and Impact of F70A and F108Y Substitutions on Substrate Specificity

  2023cites this paper
• Hemicyanine-Based Near-Infrared Fluorescence Off–On Probes for Imaging Intracellular and In Vivo Nitroreductase Activity

  2023cites this paper
• Chemiluminescent Probes Based on 1,2-dioxetane Structures For Bioimaging.

  2022cites this paper
• Metabolic pathway of Cr(VI) reduction by bacteria: A review.

  2022cites this paper
• Oxygen‐insensitive nitroreductase E. coli NfsA, but not NfsB, is inhibited by fumarate

  2022cites this paper
• Development of a nitroreductase-dependent theranostic payload for antibody-drug conjugate.

  2022cites this paper
• Significance of Specific Oxidoreductases in the Design of Hypoxia-Activated Prodrugs and Fluorescent Turn off–on Probes for Hypoxia Imaging

  2022cites this paper
• Sequence Conservation Does Not Always Signify a Functional Imperative as Observed in the Nitroreductase Superfamily.

  2022cites this paper
• In Vivo Dopamine Neuron Imaging-Based Small Molecule Screen Identifies Novel Neuroprotective Compounds and Targets

  2022cites this paper
• Interrogation of the Structure–Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications

  2022cites this paper
• Synthesis and biological evaluation of prodrugs for nitroreductase based 4-β-amino-4′-Demethylepipodophyllotoxin as potential anticancer agents

  2022cites this paper
• Application of Gene-Directed Enzyme Prodrug Therapy in Cancer Treatment

  2021cites this paper
• Neural Progenitor Cells Expressing Herpes Simplex Virus-Thymidine Kinase for Ablation Have Differential Chemosensitivity to Brivudine and Ganciclovir

  2021cites this paper
• Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411NTR leading to therapeutic benefit

  2021cites this paper
• Photocatalytic Nitroaromatic Prodrug Activation by Functionalized Gold Nanoclusters

  2021cites this paper
• Versatile selective evolutionary pressure using synthetic defect in universal metabolism

  2021cites this paper
• Flavin oxidation state impacts on nitrofuran antibiotic binding orientation in nitroreductases.

  2021cites this paper
• Engineering the Escherichia coli Nitroreductase NfsA to Create a Flexible Enzyme-Prodrug Activation System

  2021cites this paper
• A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons

  2021cites this paper
• The structures of E. coli NfsA bound to the antibiotic nitrofurantoin; to 1,4-benzoquinone and to FMN

  2021cites this paper
• Clostridium cellulovorans Proteomic Responses to Butanol Stress

  2021cites this paper
• Step-by-Step Immune Activation for Suicide Gene Therapy Reinforcement

  2021cites this paper
• Gold Nanoclusters Perform Enzyme-like Photocatalysis for Prodrug Activation

  2021cites this paper
• NTR 2.0: a rationally-engineered prodrug converting enzyme with substantially enhanced efficacy for targeted cell ablation

  2021cites this paper
• 1,8-Naphthalimide based fluorescent sensors for enzymes

  2021cites this paper
• The YfkO Nitroreductase from Bacillus Licheniformis on Gold-Coated Superparamagnetic Nanoparticles: Towards a Novel Directed Enzyme Prodrug Therapy Approach

  2021cites this paper
• Repurposing 18F-FMISO as a PET tracer for translational imaging of nitroreductase-based gene directed enzyme prodrug therapy

  2021cites this paper
• Single- and Two-Electron Reduction of Nitroaromatic Compounds by Flavoenzymes: Mechanisms and Implications for Cytotoxicity

  2021influential citation
• 0 Repurposing 18 F-FMISO as a PET tracer for translational imaging of 1 nitroreductase-based gene directed enzyme prodrug therapy . 2

  2021cites this paper
• Structure and substrate specificity determinants of NfnB, a dinitroaniline herbicide–catabolizing nitroreductase from Sphingopyxis sp. strain HMH

  2021cites this paper
• Synthesis and Evaluation of New Dinitrobenzamide Mustards in Human Prostate Cancer.

  2020cites this paper
• Protocol for evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative bacterial vector

  2020cites this paper
• An EDTA-resistant pyrazinamidase from non-pathogen Pseudonocardia carboxydivorans

  2020cites this paper
• A giant leap in sequence space reveals the intracellular complexities of evolving a new function

  2020cites this paper
• Transcriptomic comparison of two selective retinal cell ablation paradigms in zebrafish reveals shared and cell-specific regenerative responses

  2020cites this paper
• Directed evolution of the B. subtilis nitroreductase YfkO improves activation of the PET-capable probe SN33623 and CB1954 prodrug

  2020cites this paper
• E. coli nitroreductase NfsA is a reporter gene for non-invasive PET imaging in cancer gene therapy applications

  2020cites this paper
• Evaluation of two xenobiotic reductases from Pseudomonas putida for their suitability for magnetic nanoparticle‐directed enzyme prodrug therapy as a novel approach to cancer treatment

  2020influential citation
• Designing Hypoxia‐Responsive Nanotheranostic Agents for Tumor Imaging and Therapy

  2020cites this paper
• Evolutionary aspects of the Viridiplantae nitroreductases

  2020influential citation
• Ag–Pd Alloy Immobilized on Semi-heterogeneous Support as a Novel Highly Efficient Artificial Nitroreductase: Experimental Design Optimization and Kinetic Study

  2020cites this paper
• Microbial nitroreductases: A versatile tool for biomedical and environmental applications

  2020cites this paper
• Self-Calibrating Bipartite Fluorescent Sensor for Nitroreductase Activity and Its Application to Cancer and Hypoxic Cells.

  2020cites this paper
• Intracellular complexities of acquiring a new enzymatic function revealed by mass-randomisation of active-site residues

  2020cites this paper
• Directed evolution of the B. subtilis nitroreductase YfkO improves activation of the PET-capable probe SN33623 and CB1954 prodrug

  2020cites this paper
• NTR 2.0: a rationally-engineered prodrug converting enzyme with substantially enhanced efficacy for targeted cell ablation

  2020cites this paper
• Nitroreductase‐Mediated Release of Inhibitors of Lysine‐Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells†

  2019cites this paper
• A resorufin-based fluorescent turn-on probe responsive to nitroreductase activity and its application to bacterial detection

  2019cites this paper
• PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY- 2: Novel amide/Ntr combinations targeting PC3 cancer cells.

  2019cites this paper
• A Double Fail-Safe Approach to Prevent Tumorigenesis and Select Pancreatic β Cells from Human Embryonic Stem Cells

  2019cites this paper
• Targeted Antibacterial Activity Guided by Bacteria-Specific Nitroreductase Catalytic Activation to Produce Ciprofloxacin.

  2019cites this paper
• Time dependent HPLC analysis of the product ratio of enzymatically reduced prodrug CB1954 by a modified and immobilised nitroreductase

  2019cites this paper
• Cell-Penetrating Peptides as a Tool for the Cellular Uptake of a Genetically Modified Nitroreductase for use in Directed Enzyme Prodrug Therapy

  2019cites this paper
• Engineering Escherichia coli NfsB to activate a hypoxia-resistant analog of the PET probe EF5 to enable non-invasive imaging during enzyme-prodrug therapy.

  2019cites this paper
• A cofactor consumption screen identifies promising NfsB family nitroreductases for dinitrotoluene remediation

  2019cites this paper
• Versatile cell ablation tools and their applications to study loss of cell functions

  2019cites this paper
• Coumarin-Quinazolinone conjugate with large two photon action cross-section assisted by intramolecular hydrogen bond for bioimaging

  2019cites this paper
• Small-molecule fluorescent probes for specific detection and imaging of chemical species inside lysosomes.

  2019cites this paper
• Prodrugs for targeted cancer therapy

  2019influential citation
• Activatable Probes for Anti-Cancer Therapy

  2019cites this paper
• Pancreatic Diseases: The Role of Stem Cells

  2019cites this paper
• Investigating the evolvability of 'Escherichia coli nfsA' via simultaneous site-directed mutagenesis

  2019cites this paper
• Pt(II)-Based Artificial Nitroreductase: An Efficient and Highly Stable Nanozyme

  2019cites this paper
• pH- and enzyme-triggered drug release as an important process in the design of anti-tumor drug delivery systems.

  2019cites this paper
• Biochemical characteristics of a nitroreductase with diverse substrate specificity from Streptomyces mirabilis DUT001

  2018cites this paper
• Enzyme-Activated Fluorogenic Probes for Live-Cell and in Vivo Imaging.

  2018cites this paper
• Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.

  2018cites this paper
• Informing Efforts to Develop Nitroreductase for Amine Production

  2018cites this paper
• Evaluation of NfsA-like nitroreductases from Neisseria meningitidis and Bartonella henselae for enzyme-prodrug therapy, targeted cellular ablation, and dinitrotoluene bioremediation

  2018cites this paper